Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
20
NCT04167540
GDNF Gene Therapy for Parkinson's Disease
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 1, 2020
Completion: Jun 30, 2027
NCT04680065
GDNF Gene Therapy for Multiple System Atrophy
Start: Oct 3, 2023
Completion: Aug 31, 2028